Tran L, Chia J, Le Guezennec X, Tham K, Nguyen A, Sandrin V
Nat Commun. 2025; 16(1):2535.
PMID: 40087276
DOI: 10.1038/s41467-025-57401-9.
Oyende Y, Taus L, Fatatis A
Cancers (Basel). 2025; 17(2).
PMID: 39858071
PMC: 11763358.
DOI: 10.3390/cancers17020290.
Tomecka P, Kunachowicz D, Gorczynska J, Gebuza M, Kuznicki J, Skinderowicz K
Int J Mol Sci. 2024; 25(16).
PMID: 39201656
PMC: 11354349.
DOI: 10.3390/ijms25168972.
Arakil N, Akhund S, Elaasser B, Mohammad K
Biomedicines. 2024; 12(5).
PMID: 38791037
PMC: 11117796.
DOI: 10.3390/biomedicines12051075.
Lomovskaya Y, Krasnov K, Kobyakova M, Kolotova A, Ermakov A, Senotov A
Acta Naturae. 2024; 16(1):48-58.
PMID: 38698963
PMC: 11062100.
DOI: 10.32607/actanaturae.27317.
GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.
Yang Y, Song S, Li S, Kang J, Li Y, Zhao N
Cell Death Dis. 2024; 15(4):289.
PMID: 38653973
PMC: 11039647.
DOI: 10.1038/s41419-024-06656-z.
Vitamin A, D, E, and K as Matrix Metalloproteinase-2/9 Regulators That Affect Expression and Enzymatic Activity.
Vo H, Nguyen Y, Kim N, Lee H
Int J Mol Sci. 2023; 24(23).
PMID: 38069361
PMC: 10707015.
DOI: 10.3390/ijms242317038.
The Effect of Adipocyte-Secreted Factors in Activating Focal Adhesion Kinase-Mediated Cell Signaling Pathway towards Metastasis in Breast Cancer Cells.
Mubtasim N, Gollahon L
Int J Mol Sci. 2023; 24(23).
PMID: 38068928
PMC: 10706115.
DOI: 10.3390/ijms242316605.
TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization.
Tang J, Kang Y, Zhou Y, Shang N, Li X, Wang H
J Clin Invest. 2023; 134(3).
PMID: 38015626
PMC: 10849766.
DOI: 10.1172/JCI164199.
Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
Lyu A, Humphrey R, Nam S, Durham T, Hu Z, Arasappan D
Nat Commun. 2023; 14(1):6270.
PMID: 37805579
PMC: 10560206.
DOI: 10.1038/s41467-023-41925-z.
Blocking the Hormone Receptors Modulates NLRP3 in LPS-Primed Breast Cancer Cells.
Hamza S, Garanina E, Alsaadi M, Khaiboullina S, Tezcan G
Int J Mol Sci. 2023; 24(5).
PMID: 36902278
PMC: 10002867.
DOI: 10.3390/ijms24054846.
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Habanjar O, Bingula R, Decombat C, Diab-Assaf M, Caldefie-Chezet F, Delort L
Int J Mol Sci. 2023; 24(4).
PMID: 36835413
PMC: 9964711.
DOI: 10.3390/ijms24044002.
(-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells.
Sah D, Khoi P, Li S, Arjunan A, Jeong J, Do Jung Y
Int J Mol Sci. 2022; 23(22).
PMID: 36430487
PMC: 9697952.
DOI: 10.3390/ijms232214008.
Src Family Kinases Facilitate the Crosstalk between CGRP and Cytokines in Sensitizing Trigeminal Ganglion via Transmitting CGRP Receptor/PKA Pathway.
Nie L, Sun K, Gong Z, Li H, Quinn J, Wang M
Cells. 2022; 11(21).
PMID: 36359895
PMC: 9655983.
DOI: 10.3390/cells11213498.
Autologous Extracellular Vesicles Attenuate Cardiac Injury in Experimental Atherosclerotic Renovascular Disease More Effectively Than Their Parent Mesenchymal Stem/Stromal Cells.
Hong S, Zhu X, Jiang Y, Zhang L, Tang H, Jordan K
Stem Cell Rev Rep. 2022; 19(3):700-712.
PMID: 36344721
PMC: 10073252.
DOI: 10.1007/s12015-022-10473-2.
Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis.
Zhou J, Down J, George C, Murphy J, Lefley D, Tulotta C
Cancers (Basel). 2022; 14(19).
PMID: 36230739
PMC: 9561984.
DOI: 10.3390/cancers14194816.
Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis.
Ito A, Akama Y, Satoh-Takayama N, Saito K, Kato T, Kawamoto E
Cancers (Basel). 2022; 14(13).
PMID: 35805039
PMC: 9265472.
DOI: 10.3390/cancers14133267.
Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance.
Diep S, Maddukuri M, Yamauchi S, Geshow G, Delk N
Cells. 2022; 11(10).
PMID: 35626710
PMC: 9139516.
DOI: 10.3390/cells11101673.
FAK in Cancer: From Mechanisms to Therapeutic Strategies.
Chuang H, Zhen Y, Tsai Y, Chuang C, Hsiao M, Huang M
Int J Mol Sci. 2022; 23(3).
PMID: 35163650
PMC: 8836199.
DOI: 10.3390/ijms23031726.
Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis.
Haider M, Ridlmaier N, Smit D, Taipaleenmaki H
Int J Mol Sci. 2021; 22(6).
PMID: 33809315
PMC: 7999500.
DOI: 10.3390/ijms22062898.